Data catalog
Health Canada regulation sections cited in inspections
About 273 records
All records
Every Health Canada citation record published by Orca1, 1000 per page. Each page lists the record id and its name; open a record for key facts, related records and what Orca1 adds.
- blood-regulationsBlood regulations
- Blood regulations - blood regulations
- c-01-000-and-or-c-08-000C.01.000 and/or c.08.000
- C.01.000 and/or c.08.000 - gvp sections
- C.01.017 - serious adverse drug reaction reporting
- C.01.018 - annual summary report and case reports
- C.01.019 - issue-related summary report
- C.01.020 - maintenance of records
- C.01.050 - notification of a foreign action
- C.01.050 - notify of a serious risk of injury to human health
- C.01.050 - notify of a serious risk to human health
- c-02-000C.02.000
- c-02-0004-premisesC.02.0004- premises
- c-02-000-gmp-sectionsC.02.000 - gmp sections
- c-02-003-saleC.02.003 - sale
- c-02-004-premisesC.02.004 - premises
- c-02-005-equipmentC.02.005 - equipment
- c-02-006-personnelC.02.006 - personnel
- c-02-007-c-02-008-sanitationC.02.007 - c.02.008 - sanitation
- c-02-007-sanitationC.02.007 - sanitation
- c-02-008-sanitationC.02.008 - sanitation
- C.02.009 - c.02.010 - raw material testing
- C.02.009 - raw material testing
- C.02.010 - raw material testing
- C.02.011 - c.02.012 - manufacturing control
- C.02.011 - manufacturing control
- C.02.012 - manufacturing control
- C.02.013 - c.02.015 - quality control
- c-02-013-quality-controlC.02.013 - quality control
- C.02.013 - quality control department
- c-02-014-quality-controlC.02.014 - quality control
- C.02.014 - quality control department
- c-02-015-quality-controlC.02.015 - quality control
- C.02.015 - quality control department
- C.02.016 - c.02.017 - packaging material testing
- C.02.016 - packaging material testing
- C.02.017 - packaging material testing
- C.02.018 - c.02.019 - finished product testing
- C.02.018 - finished product testing
- C.02.019 - finished product testing
- c-02-020-c-02-024-recordsC.02.020 - c.02.024 - records
- c-02-020-recordsC.02.020 - records
- c-02-021-recordsC.02.021 - records
- c-02-022-recordsC.02.022 - records
- c-02-023-recordsC.02.023 - records
- c-02-024-recordsC.02.024 - records
- c-02-025-c-02-026-samplesC.02.025 - c.02.026 - samples
- c-02-025-samplesC.02.025 - samples
- c-02-026-samplesC.02.026 - samples
- c-02-027-c-02-028-stabilityC.02.027 - c.02.028 - stability
- c-02-027-stabilityC.02.027 - stability
- c-02-028-stabilityC.02.028 - stability
- c-02-029-sterile-productsC.02.029 - sterile products
- c-05-003-prohibitionC.05.003 - prohibition
- c-05-006-authorizationC.05.006 - authorization
- c-05-007-notificationC.05.007 - notification
- c-05-008-amendmentC.05.008 - amendment
- C.05.010 - sponsor's obligations - good clinical practices
- c-05-011-labellingC.05.011 - labelling
- c-05-012-recordsC.05.012 - records
- C.05.014 - serious unexpected adverse drug reaction reporting
- c-08-003-label-updateC.08.003 - label update
- c-08-007-new-drugsC.08.007 - new drugs
- C.08.008 (c) - unusual failure in efficacy
- c-08-008-efficacyC.08.008 - efficacy
- c-08-008-new-drugsC.08.008 - new drugs
- equipment-c-02-005Equipment - c.02.005
- fda-s-19-hazardous-devicesFDA s.19 - hazardous devices
- fda-s-20-1-misrepresentationFDA s.20 (1) - misrepresentation
- FDA s.20(1) - prohibition of misrepresentation
- FDA s.20(2) - labelling violations
- FDA s.21 - prescribed standards
- FDA s.3(1) - no schedule a claims in ads
- FDA s.3(2)(a) - schedule a label claims - no sale
- FDA s.3 (2)(b) - schedule a label claims - no sale
- FDA s.3 (3) no contraceptive ads to general public
- fda-s-37-exportsFDA s.37 - exports
- Io covid-19 s.10 - terms and conditions
- MDR s.10 - safety and effectiveness
- MDR s.14 - transport and storage
- mdr-s-21-1-a-name-of-deviceMDR s.21(1)(a) - name of device
- mdr-s-21-1-b-manufacturerMDR s.21(1)(b) - manufacturer
- MDR s.21(1)(c) - device identifier
- mdr-s-21-1-d-control-numberMDR s.21(1)(d) - control number
- mdr-s-21-1-e-contentsMDR s.21(1)(e) - contents
- mdr-s-21-1-g-expiry-dateMDR s.21(1)(g) - expiry date
- MDR s.21(1)(h) - medical conditions
- MDR s.21(1)(i) - directions for use
- MDR s.21(1)(j) - storage conditions
- MDR s.21 (1) labelling deficiencies
- MDR s.21(1) - labelling requirements
- MDR s.21 (1) multiple label deficiencies
- MDR s.21(1) - multiple labelling deficiencies
- mdr-s-21-1-no-labelMDR s.21 (1) no label
- mdr-s-21-2-legibilityMDR s.21(2) - legibility
- mdr-s-21-s-23-labellingMDR s.21 - s.23 - labelling
- MDR s.22(1) - placement for general public
- MDR s.23(1) - official languages
- MDR s.23(1) - sale to general public - bilingual requirements
- MDR s.23(2) - bilingual directions for use
- MDR s.23 (2) directions for use - bilingual option
- MDR s.23(3) - sale to general public - bilingual requirements
- MDR s.26, mdr 27 - sale or advertising of unauthorized devices
- MDR s.26 - no sale or import of unlicensed devices
- MDR s.26 - sale or advertising of unauthorized devices
- MDR s.27 (a) no advertising of unlicensed devices
- MDR s.27(a) - no advertising unlicensed devices
- MDR s.27(b) - catalogue advertising of devices
- MDR s.27 - no sale or import of unlicensed devices
- MDR s.27 - sale or advertising of unauthorized devices
- MDR s.44 (1) no sale or import without establishment licence
- MDR s.44(1) - sale or import without establishment licence
- MDR s.44(3) - import from company without establishment licence
- MDR s.44 - establishment licensing
- MDR s.45(a) - name and address of establishment
- MDR s.45(b) - name, title, phone number of el contact person
- mdr-s-45-c-activitiesMDR s.45(c) - activities
- MDR s.45 - distribution records
- MDR s.45(d) - names of manufacturers
- MDR s.45 - establishment licensing
- mdr-s-45-f-device-classesMDR s.45(f) - device classes
- MDR s.45(g) - distribution, complaints, recalls
- MDR s.45(g) - distribution records
- mdr-s-45-g-proceduresMDR s.45(g) - procedures
- MDR s.45(h.1) - incident reporting
- MDR s.45 (h.1) incident reporting and/or provision of information in respect of serious…
- MDR s.45(h.1) - provision of information related to risk
- MDR s.45(h.1) - provision of information related to serious risk of injury to human health
- MDR s.45 - handling, storage or delivery
- MDR s.45(h)-(h.1) - incident reporting
- MDR s.45(h) - incident reporting
- MDR s.45(h) - mandatory problem reporting
- MDR s.45(h) - mandatory problem reports
- mdr-s-45-h-proceduresMDR s.45(h) - procedures
- mdr-s-45-i-corrective-actionMDR s.45(i) - corrective action
- MDR s.45(i) - handling storage and delivery, etc.
- MDR s.45(i) - handling, storage, delivery, etc.
- mdr-s-45-incident-reportingMDR s.45 - incident reporting
- mdr-s-45-j-listed-sitesMDR s.45(j) - listed sites
- MDR s.45, mdr s.52 - mdr s.56 - distribution records
- mdr-s-45-problem-reportingMDR s.45 - problem reporting
- mdr-s-45-proceduresMDR s.45 - procedures
- MDR s.45 - provision of information related to serious risk of injury to human health
- MDR s.48 - establishment licence changes
- MDR s.48 - establishment licensing
- MDR s.48 notification with respect to change to 45(a),(b) in 15 days
- MDR s.52(1) - distribution records per device
- MDR s.52 - mdr s.56 - distribution records
- MDR s.53 - sufficient for product withdrawal
- MDR s.53 sufficient information for complete and rapid recall
- mdr-s-55-retention-timeMDR s.55 - retention time
- mdr-s-56-timely-availabilityMDR s.56 - timely availability
- MDR s.57(1)(a) - records of problems
- MDR s.57 (1)(a) records of problems, complaints
- MDR s.57(1)(b) - records of actions taken
- mdr-s-57-complaintsMDR s.57 - complaints
- mdr-s-58-a-complaintsMDR s.58(a) - complaints
- MDR s.58(a) - investigation procedure
- MDR s.58 b, mdr s.64 - recall reporting
- mdr-s-58-b-recall-procedureMDR s.58(b) - recall procedure
- mdr-s-58-b-recall-reportingMDR s.58(b) - recall reporting
- mdr-s-58-b-recallsMDR s.58(b) - recalls
- MDR s.59(1) - incident reporting
- MDR s.59(1) - mandatory problem reporting
- MDR s.59(1) - obligation to report
- MDR s.59(2) - mandatory problems outside canada
- MDR s.59-61.1 - incident reporting
- MDR s.59 - s.61 - problem reporting
- MDR s.59 - s61 - problem reporting
- MDR s.60(1)(a)(ii) - preliminary report - 30 days
- MDR s.60(1)(a)(i) - preliminary report - 10 days
- MDR s.60(1)(b) - time limits - outside canada
- MDR s.60(2)(a)-(i) - contents of preliminary report
- MDR s.60(2)(a)-(i) - incident reporting
- MDR s.61 (1) submission of final report with respect to 60(2)(h)
- MDR s.61(1) - submit final report with respect to 60(2)(h)
- MDR s.61.2(2) - provision of information on serious risk of injury to human health
- MDR s.61.2(2) - provision of information related to serious risk of injury to human health
- MDR s.61.2 (3) provision of information in respect of risk within 72 hours
- MDR s.61.2(3) - provision of information related to serious risk of injury to human health
- MDR s.61 (2)(b) incident report - cause and actions taken
- MDR s.61(2) - incident reporting
- MDR s.61(2) - mandatory problem reports
- MDR s.61.4 (1)(a) preparation of summary reports for class ii medical devices
- MDR s.61.4 (1)(b) preparation of summary reports for class iii or iv medical devices
- mdr-s-61-4-1-summary-reportsMDR s.61.4(1) - summary reports
- mdr-s-61-4-2-summary-reportsMDR s.61.4(2) - summary reports
- MDR s.61.4-s.61.6 - summary reports
- MDR s.63.2 (a)-(g) contents of recall notification
- MDR s.63.2 recall notification within 24 hours
- MDR s.64 (a) - (k) - contents of initial recall report
- MDR s.64 (a)-(n) contents of initial recall report
- mdr-s-64-recall-reportingMDR s.64 - recall reporting
- MDR s.64 - submit initial recall report
- MDR s.64 timeline requirement for initial recall report
- mdr-s-64-unreported-recallMDR s.64 unreported recall
- MDR s.65.4 recall records for distributor
- MDR s.65(a),(b) - contents of final recall report
- mdr-s-65-recall-reportingMDR s.65 - recall reporting
- MDR s.65 - submit final recall report
- MDR s.65 timeline requirement for final recall report
- MDR s.70 - no sale/import without authorization
- MDR s.75(a)-(c) - specific labelling
- MDR s.75 - custom-made devices and special access
- MDR s.76 - distribution records
- MDR s.76 distribution records per device
- MDR s.80(2) - authorization and records
- MDR s.87(b) - investigational device - advertising
- MDR s.89(1) - export certificates
- mdr-s-91-export-certificatesMDR s.91 - export certificates
- MDR s.9(1) - safety and effectiveness - obligations
- MDR s.9 (2) safety and effectiveness - evidence
- Quality control department - c.02.015
- S.3(2)(a) - schedule a label claims - no sale
- section-100-equipmentSection 100 - equipment
- Section 100 - personnel, facilities, equipment and supplies
- section-101-equipmentSection 101 - equipment
- Section 101 - personnel, facilities, equipment and supplies
- Section 102 - personnel, facilities, equipment and supplies
- section-102-suppliesSection 102 - supplies
- Section 103 - errors and accidents
- Section 104 - errors and accidents
- Section 107 - investigation and reporting
- Section 108 - investigation and reporting
- Section 110 - adverse recipient reactions
- Section 112 - investigation and reporting of adverse recipient reactions
- Section 113 - investigation and reporting of adverse recipient reactions
- Section 114 - investigation and reporting of adverse recipient reactions
- section-117-recordsSection 117 - records
- section-118-recordsSection 118 - records
- section-119-recordsSection 119 - records
- section-121-recordsSection 121 - records
- section-122-recordsSection 122 - records
- Section 23 - establishment licences
- section-31-registrationSection 31 - registration
- section-33-registrationSection 33 - registration
- section-38-58-processingSection 38-58 - processing
- Section 39 - donor suitability assessment
- Section 41 - donor suitability assessment
- Section 42 - donor suitability assessment
- Section 44 - donor suitability assessment
- section-45-collectionSection 45 - collection
- section-48-collectionSection 48 - collection
- section-49-collectionSection 49 - collection
- section-51-collectionSection 51 - collection
- section-52-testingSection 52 - testing
- Section 5-37 - authorizations, establishment licenses and registrations
- section-59-68-labellingSection 59-68 - labelling
- section-61-labellingSection 61 - labelling
- section-64-labellingSection 64 - labelling
- section-65-labellingSection 65 - labelling
- section-68-labellingSection 68 - labelling
- section-69-72-storageSection 69-72 - storage
- section-69-storageSection 69 - storage
- section-70-storageSection 70 - storage
- section-73-76-distributionSection 73-76 - distribution
- section-75-distributionSection 75 - distribution
- section-76-distributionSection 76 - distribution
- section-77-80-transformationSection 77-80 - transformation
- section-77-transformationSection 77 - transformation
- section-78-transformationSection 78 - transformation
- section-79-transformationSection 79 - transformation
- section-80-transformationSection 80 - transformation
- Section 93-123 - quality management
- Section 93 - quality management system
- Section 94 - quality management system
- Section 95 - operating procedures
- Section 96 - operating procedures
- Section 97 - operating procedures
- section-98-personnelSection 98 - personnel
- Section 98 - personnel, facilities, equipment and supplies
- section-99-facilitiesSection 99 - facilities
- Section 99 - personnel, facilities, equipment and supplies
About this dataset
Health Canada inspection reports cite the section of the Food and Drug Regulations, Medical Devices Regulations or Blood Regulations behind each observation. This page counts the published inspections that cite the requirement.
Source: Health Canada, Drug and Health Product Inspections; citation counts by Orca1. Contains information licensed under the Open Government Licence – Canada